ICWRSA Annual Report January 2020 – December 2021 

Sivananthi Thananthiran, Asian-Pacific Resource and Research Centre for Women (ARROW), Malaysia – Beverly Winikoff, Gynuity Health Projects, USA International Advisory Group (2020-2021) Heads of affiliated regional networks – Shruti Arora,

Round-up of stories from the USA

to term.” SOURCE (excerpts): New York Times, by Sabrina Tavernise, 26 September 2021 +++ Gynuity Health Projects TelAbortion study will stop enrolling end of September 2021 This ground-breaking research project,

Region: USA |

MEDIA AND PRESS ARTICLES FOR 28 SEPTEMBER 2020

Gynuity Health Projectswrote a special newsletter for 28 September celebrating all those around the globe who work tirelessly to provide safe abortion services and the date as the 20th anniversary

JOURNAL ARTICLES: ESSENTIAL READING

contact between patients and providers. Gynuity recently led a collaborative development of a sample protocol for providing abortion pills without any routine facility-based tests either before or after treatment. They

THE MEDICINES SUPPLY CHAIN

September 2018, the International Planned Parenthood Federation, Gynuity Health Projects and the Concept Foundation launched the Medical Abortion Commodities Database to help those working on safe abortiontoidentify quality products to

REPORTS FROM COUNTRIES

possible (or necessary) forall patients. Gynuity is committed to conducting ground-breakingresearch helping to develop new clinical care models. Gynuity Health Projects. E-mail, 20 March 2020 +++ Ohio abortionproviders told to

TEL-ABORTION SERVICES EXPAND TO TEN STATES

Gynuity Health Projects writes: As part of our effort toimprove access to abortion care, especially among populations who may facebarriers, we recently launched the Spanish version of our TelAbortion website.Both

REGISTERING MIFEPRISTONE FOR OTHER INDICATIONS

health care providers. More indications could also increasedemand, and… may in turn generate interest by pharmaceutical companies topursue its marketing and distribution… Gynuity Health Projects has worked for almost two

SECOND TRIMESTER MA AS A DAY SERVICE

six clinical studies of second-trimester medical abortion conducted by Gynuity Health Projects over the past 10 years. We include 868 individuals receiving mifepristone–misoprostol abortion between 13 and 22 weeks’ gestation.